Anabolic Steroid • Oral • Schedule III

Superdrol: The Designer Steroid That Fooled Regulators

Last updated: March 2026

Methasterone (Superdrol) was sold as a legal dietary supplement from 2005 to 2012, producing extreme dry muscle gains before the FDA intervened. It remains one of the most hepatotoxic orals ever used, with multiple case reports of acute liver failure. This reference covers the pharmacology, risks, and harm-reduction evidence.

0
Community Dose Range
per Day
0
Anabolic Rating
(vs. Testosterone = 100)
0
Year FDA Banned
as Supplement

How Superdrol Works

Methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3-one) is a structurally modified DHT derivative with two key methylations that make it potent, dry, and exceptionally liver-toxic.

🧬
Dual Methylation — Potency & Toxicity

Superdrol has methylation at both the 2α and 17α positions. The 17α-methyl allows oral survival (same as Anadrol, Dianabol). The 2α-methyl dramatically increases anabolic potency. Together, they create a compound with an anabolic rating ~4× testosterone — but the combined methylations impose extreme hepatic stress that exceeds most other oral steroids.

💎
No Aromatization — Dry Gains

Methasterone is a DHT derivative and does not undergo aromatase-mediated conversion to estradiol. This produces characteristically dry, dense muscle with minimal water retention — a contrast to Anadrol or Dianabol. Gynecomastia risk is low, but estrogenic suppression of HDL still occurs via androgenic mechanisms.

⚠️
Cholestatic Hepatitis — Unique Toxicity Pattern

Case reports document Superdrol causing cholestatic hepatitis (bile flow disruption) progressing to acute liver failure within 4-12 weeks of use. This pattern is more severe than typical 17α-AA hepatotoxicity and is not reliably prevented by standard liver support. The 2α-methyl group appears to amplify bile salt export pump inhibition.

📉
HPTA Suppression & Lipid Disruption

Superdrol causes rapid, near-complete suppression of LH and FSH, shutting down endogenous testosterone. This requires a full PCT protocol post-cycle. HDL cholesterol drops sharply (50-70% in community reports), while LDL increases. This lipid impact compounds cardiovascular risk beyond what liver function tests capture.

What the Evidence Shows

Limited clinical trial data exists — most evidence comes from case reports, in vitro studies, and community-reported outcomes (labeled).

Anabolic Potency vs. Testosterone (In Vitro)
Receptor binding affinity studies — not clinical data
~400%
Community-Reported Lean Mass Gain (3-4 weeks)
Anecdotal — forums and community surveys
4-8 lbs lean
HDL Suppression
Community-reported lipid impact — anecdotal
50-70% drop
Liver Enzyme Elevation (ALT/AST)
Case report data — severe cholestatic pattern
5-10× ULN
HPTA Suppression
Near-complete in community reports — requires PCT
~95%

Risks & Side Effects

Hepatotoxicity
Extreme — cholestatic hepatitis, liver failure cases documented
Extreme
Lethargy / Fatigue
Community-reported — most common side effect
Very Common
Cardiovascular (Lipid Dysregulation)
HDL crash, LDL elevation — significant CVD risk modifier
Severe
Blood Pressure Elevation
Moderate increase — monitor daily during cycle
Moderate
Androgenic Side Effects
Acne, hair loss — DHT-derived compound
Moderate

Key Takeaways

✅ What We Know
  • Methasterone has ~400× anabolic rating vs testosterone in receptor studies
  • Does NOT aromatize — produces dry, hard, water-free gains
  • FDA-banned as a supplement in 2012, now Schedule III controlled substance
  • 3-4 week cycles are the maximum in community harm-reduction practice
  • TUDCA is the most commonly recommended liver support co-administration
  • Lethargy is extremely common — a known dose-dependent effect
🚨 Critical Risks
  • Multiple documented liver transplant cases linked to Superdrol use
  • Cholestatic hepatitis pattern may not respond to standard liver support
  • HDL crash is among the worst of any oral steroid — serious CVD risk
  • No human clinical trial data — safety profile based on case reports only
  • Do NOT stack with other 17α-alkylated orals or alcohol

🛒 Liver Support & Monitoring

Liver protection and lipid monitoring are critical harm-reduction practices for any oral steroid research.

Related Resources

📚

Want the Complete Protocol Guide?

Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.


Get the Guide →
⚠️ Legal & Medical Disclaimer

This page is for educational and harm-reduction purposes only. Methasterone (Superdrol) is a Schedule III controlled substance under the Anabolic Steroid Control Act and was banned as a dietary supplement by the FDA in 2012. Possession without a valid prescription is illegal in the United States and many other countries. This content does not constitute medical advice. Multiple documented cases of serious liver injury, including acute liver failure, have been associated with this compound. Always consult a licensed physician before using any anabolic agent.